Wedbush Upgrades Harpoon Therapeutics (HARP) to Outperform
Tweet
Share
E-mailGet Alerts HARP Hot Sheet
Price: $23.01 --0%
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Join SI Premium – FREE
Wedbush analyst Robert Driscoll upgraded Harpoon Therapeutics (NASDAQ: HARP) from Neutral to Outperform with a price target of $7.00 (from $5.00).
For an analyst ratings summary and ratings history on Harpoon Therapeutics click here. For more ratings news on Harpoon Therapeutics click here.
Shares of Harpoon Therapeutics closed at $2.00 yesterday.
You May Also Be Interested In
- Alto Neuroscience (ANRO) PT Raised to $55 at H.C. Wainwright
- JCR Pharmaceuticals Co Ltd (4552:JP) PT Raised to JPY540 at Nomura/Instinet
- Sansan Inc (4443:JP) PT Raised to JPY2,400 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
